Please login to the form below

Not currently logged in
Email:
Password:

volanesorsen

This page shows the latest volanesorsen news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Akcea’s rare inherited disorder drug Waylivra

NICE rejects Akcea’s rare inherited disorder drug Waylivra

Waylivra (volanesorsen) is an antisense drugs, used for the treatment of a rare inherited disorder called familial chylomicronemia syndrome (FCS). ... As a patient-focused company, we are dedicated to supporting patients with FCS and those patients who

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....